|
|
Article: Researchers from University of Munich report on findings in cytomegalovirus.
- Article from:
- Blood Weekly
- Article date:
- October 15, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
According to a study from Munich, Germany, "Recently published data from our center have demonstrated the feasibility of a nephrotoxicity- and atherogenicity-free, mycophenolate mofetil (MMF)-based immunosuppressive protocol for elderly recipients of kidneys from elderly cadaveric donors. We investigated a therapeutic regimen of strictly monitored MMF (target mycophenolic acid [MPA] trough levels between 2-6 mu g/mL) and steroids combined with a polyclonal-monoclonal induction regimen consisting of a low-dose, single shot of rabbit ATG (ATG-Fresenius) and the interleukin-2 receptor (IL-2R)-antibody basiliximab (d0 and d4)."
"Between 1997 and 2007, we treated 175 ...
Related newspaper, magazine, and journal articles:
|
|
Article: Reports outline liver transplant research from Technical ...
Blood Weekly;
August 7, 2008 ;
700+ words
... ... in a rat model. Transplantation Proceedings, 2008;40(4 ... Technical University of Munich, Dept. of Surgery ... Str 22, D-81675 Munich, Germany. Publisher ... information for the journal Transplantation Proceedings is: Elsevier Science ... Keywords: Germany, Munich, Bioengineering ...
|
|